View Future GrowthFlask 過去の業績過去 基準チェック /06Flaskは11.9%の年平均成長率で業績を伸ばしているが、Semiconductor業界はgrowingで0.2%毎年増加している。売上は成長しており、年平均4.1%の割合である。主要情報11.90%収益成長率40.82%EPS成長率Semiconductor 業界の成長23.50%収益成長率4.15%株主資本利益率-149.48%ネット・マージン-177.29%前回の決算情報31 Mar 2024最近の業績更新Reported Earnings • Apr 02Full year 2023 earnings released: ₩287 loss per share (vs ₩178 loss in FY 2022)Full year 2023 results: ₩287 loss per share (further deteriorated from ₩178 loss in FY 2022). Revenue: ₩22.8b (down 39% from FY 2022). Net loss: ₩37.5b (loss widened 75% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 26Full year 2022 earnings released: ₩188 loss per share (vs ₩237 loss in FY 2021)Full year 2022 results: ₩188 loss per share. Revenue: ₩39.7b (up 65% from FY 2021). Net loss: ₩22.6b (loss widened 15% from FY 2021).Reported Earnings • Nov 19Third quarter 2020 earnings released: ₩34.00 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩10.0b (up 36% from 3Q 2019). Net loss: ₩2.63b (loss narrowed 65% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 49% per year whereas the company’s share price has fallen by 47% per year.すべての更新を表示Recent updatesお知らせ • Mar 17Flask Co., Ltd., Annual General Meeting, Mar 31, 2026Flask Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 167, songpa-daero, songpa-gu, seoul South Koreaお知らせ • Mar 18Flask Co., Ltd., Annual General Meeting, Mar 31, 2025Flask Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 11, beobwon-ro 11-gil, songpa-gu, seoul South Koreaお知らせ • Nov 30Flask Co., Ltd. announced that it expects to receive KRW 11.999999625 billion in funding from B&M HoldingsFlask Co., Ltd. announced a private placement of 15,209,125 common shares at a price of KRW 789 for gross proceeds of KRW 11,999,999,625 on November 29, 2024. The transaction includes participation from returning investor, B&M Holdings. The transaction has been approved by the board of directors of the company. The payment date of the transaction is December 20, 2024. The issuance is subject to full protection for 1 year.Reported Earnings • Apr 02Full year 2023 earnings released: ₩287 loss per share (vs ₩178 loss in FY 2022)Full year 2023 results: ₩287 loss per share (further deteriorated from ₩178 loss in FY 2022). Revenue: ₩22.8b (down 39% from FY 2022). Net loss: ₩37.5b (loss widened 75% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.お知らせ • Mar 14Flask Co., Ltd. announced that it expects to receive KRW 14.9999994 billion in fundingFlask Co., Ltd. announced a private placement to issue 16,666,666 shares at an issue price of KRW 900 for the gross proceeds of KRW 14,999,999,400 on March 13, 2024. The transaction will include participation from new investor Human Wellness for 16,666,666 shares. The transaction has been approved by the shareholders of the company and is expected to close on March 18, 2024. The securities are restricted to a hold period of 1 year.分析記事 • Mar 06Some Confidence Is Lacking In Flask Co., Ltd.'s (KOSDAQ:041590) P/SWhen close to half the companies in the Semiconductor industry in Korea have price-to-sales ratios (or "P/S") below...New Risk • Nov 14New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩130.4b (US$98.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (5.4% increase in shares outstanding). Market cap is less than US$100m (₩130.4b market cap, or US$98.7m).New Risk • Oct 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (8.6% increase in shares outstanding).New Risk • Oct 10New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩128.9b (US$95.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Shareholders have been diluted in the past year (8.6% increase in shares outstanding). Market cap is less than US$100m (₩128.9b market cap, or US$95.8m).Reported Earnings • Mar 26Full year 2022 earnings released: ₩188 loss per share (vs ₩237 loss in FY 2021)Full year 2022 results: ₩188 loss per share. Revenue: ₩39.7b (up 65% from FY 2021). Net loss: ₩22.6b (loss widened 15% from FY 2021).Valuation Update With 7 Day Price Move • Feb 28Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩2,120, the stock trades at a trailing P/E ratio of 29.9x. Average trailing P/E is 17x in the Semiconductor industry in South Korea. Total returns to shareholders of 3.9% over the past three years.Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₩2,680, the stock trades at a trailing P/E ratio of 28.9x. Average trailing P/E is 17x in the Semiconductor industry in South Korea. Total returns to shareholders of 26% over the past three years.Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₩1,310, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 16x in the Semiconductor industry in South Korea. Total loss to shareholders of 47% over the past three years.お知らせ • Aug 20GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) acquired additional 12.99% stake in Gemvaxzio Co., Ltd. (KOSDAQ:A041590) for KRW 18.02 billion.GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) acquired additional 12.99% stake in Gemvaxzio Co., Ltd. (KOSDAQ:A041590) for KRW 18.02 billion on August 19, 2021. GemVax&KAEL acquired 10.8 million shares through its own funds and now holds 23.64% stake after completion of the transaction. GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) completed the acquisition of additional 12.99% stake in Gemvaxzio Co., Ltd. (KOSDAQ:A041590) on August 19, 2021.分析記事 • Apr 10Investors Will Want Gemvaxzio's (KOSDAQ:041590) Growth In ROCE To PersistIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...分析記事 • Mar 06What Type Of Returns Would Gemvaxzio's(KOSDAQ:041590) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?Long term investing is the way to go, but that doesn't mean you should hold every stock forever. It hits us in the gut...分析記事 • Jan 12Gemvaxzio (KOSDAQ:041590) Is Carrying A Fair Bit Of DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Is New 90 Day High Low • Jan 05New 90-day high: ₩847The company is up 14% from its price of ₩744 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 38% over the same period.Reported Earnings • Nov 19Third quarter 2020 earnings released: ₩34.00 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩10.0b (up 36% from 3Q 2019). Net loss: ₩2.63b (loss narrowed 65% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 49% per year whereas the company’s share price has fallen by 47% per year.お知らせ • Jul 30Enerzent Co., Ltd. (KOSDAQ:A041590) cancelled the acquisition of an unknown stake in Zio International Inc.Enerzent Co., Ltd. (KOSDAQ:A041590) agreed to acquire an unknown stake in Zio International Inc. for KRW 14.9 billion on June 3, 2019. Under the terms of the transaction, Enerzent will issue 2.8 million new shares for the consideration. Enerzent Co., Ltd. (KOSDAQ:A041590) cancelled the acquisition of an unknown stake in Zio International Inc. on June 3, 2020.お知らせ • Jul 01+ 1 more updateGemvaxzio Co., Ltd. announced that it has received KRW 12.8 billion in fundingOn June 29, 2020, Gemvaxzio Co., Ltd. (KOSDAQ:A041590) closed the transaction.お知らせ • Jun 20Gemvaxzio Co., Ltd. announced that it has received KRW 3.49999944 billion in funding from GemVax&KAEL Co.,LtdOn June 18, 2020, Gemvaxzio Co., Ltd. (KOSDAQ:A041590) closed the transaction.収支内訳Flask の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史KOSDAQ:A041590 収益、費用、利益 ( )KRW Millions日付収益収益G+A経費研究開発費31 Mar 2420,748-36,78317,55211,05631 Dec 2322,760-37,52917,33011,45730 Sep 2322,442-30,87415,1417,21230 Jun 2327,141-31,67415,7705,73231 Mar 2330,752-30,86315,0084,34431 Dec 2237,367-21,41013,3392,70430 Sep 2238,463-15,74110,1371,52730 Jun 2234,758-16,7107,70982531 Mar 2234,075-13,1705,72920031 Dec 2124,071-19,6665,425030 Sep 2136,475-8,1135,642030 Jun 2141,805-2,5145,360031 Mar 2141,008-1,1135,761031 Dec 2045,768-3305,337030 Sep 2034,694-43,7037,873030 Jun 2032,055-49,8517,8501531 Mar 2024,741-68,6377,3691531 Dec 1918,236-71,3346,9191530 Sep 1911,987-46,4603,5341530 Jun 1913,827-40,8982,958031 Mar 1921,349-20,8352,210-16431 Dec 1825,448-9,1933,467930 Sep 1829,919-4,4933,8235030 Jun 1827,873-4,8234,03231531 Mar 1825,100-6,8444,59577931 Dec 1735,808-11,9843,09776330 Sep 1718,017-7,231-4,14695730 Jun 1734,537-10,108-1,17379031 Mar 1744,468-14,3171,75459531 Dec 1647,634-18,2185,39065230 Sep 1671,705-15,96613,01268230 Jun 1652,157-14,66910,64366831 Mar 1638,953-11,6657,61473531 Dec 1544,806-8,0965,04952230 Sep 1362,6044,5235,962030 Jun 1371,1816,9195,5870質の高い収益: A041590は現在利益が出ていません。利益率の向上: A041590は現在利益が出ていません。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: A041590は利益を出していないが、過去 5 年間で年間11.9%の割合で損失を削減してきた。成長の加速: A041590の過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。収益対業界: A041590は利益が出ていないため、過去 1 年間の収益成長をSemiconductor業界 ( 5.6% ) と比較することは困難です。株主資本利益率高いROE: A041590は現在利益が出ていないため、自己資本利益率 ( -149.48% ) はマイナスです。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YSemiconductors 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2024/06/25 18:14終値2024/03/28 00:00収益2024/03/31年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Flask Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Reported Earnings • Apr 02Full year 2023 earnings released: ₩287 loss per share (vs ₩178 loss in FY 2022)Full year 2023 results: ₩287 loss per share (further deteriorated from ₩178 loss in FY 2022). Revenue: ₩22.8b (down 39% from FY 2022). Net loss: ₩37.5b (loss widened 75% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 26Full year 2022 earnings released: ₩188 loss per share (vs ₩237 loss in FY 2021)Full year 2022 results: ₩188 loss per share. Revenue: ₩39.7b (up 65% from FY 2021). Net loss: ₩22.6b (loss widened 15% from FY 2021).
Reported Earnings • Nov 19Third quarter 2020 earnings released: ₩34.00 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩10.0b (up 36% from 3Q 2019). Net loss: ₩2.63b (loss narrowed 65% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 49% per year whereas the company’s share price has fallen by 47% per year.
お知らせ • Mar 17Flask Co., Ltd., Annual General Meeting, Mar 31, 2026Flask Co., Ltd., Annual General Meeting, Mar 31, 2026, at 09:01 Tokyo Standard Time. Location: conference room, 167, songpa-daero, songpa-gu, seoul South Korea
お知らせ • Mar 18Flask Co., Ltd., Annual General Meeting, Mar 31, 2025Flask Co., Ltd., Annual General Meeting, Mar 31, 2025, at 09:00 Tokyo Standard Time. Location: conference room, 11, beobwon-ro 11-gil, songpa-gu, seoul South Korea
お知らせ • Nov 30Flask Co., Ltd. announced that it expects to receive KRW 11.999999625 billion in funding from B&M HoldingsFlask Co., Ltd. announced a private placement of 15,209,125 common shares at a price of KRW 789 for gross proceeds of KRW 11,999,999,625 on November 29, 2024. The transaction includes participation from returning investor, B&M Holdings. The transaction has been approved by the board of directors of the company. The payment date of the transaction is December 20, 2024. The issuance is subject to full protection for 1 year.
Reported Earnings • Apr 02Full year 2023 earnings released: ₩287 loss per share (vs ₩178 loss in FY 2022)Full year 2023 results: ₩287 loss per share (further deteriorated from ₩178 loss in FY 2022). Revenue: ₩22.8b (down 39% from FY 2022). Net loss: ₩37.5b (loss widened 75% from FY 2022). Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings.
お知らせ • Mar 14Flask Co., Ltd. announced that it expects to receive KRW 14.9999994 billion in fundingFlask Co., Ltd. announced a private placement to issue 16,666,666 shares at an issue price of KRW 900 for the gross proceeds of KRW 14,999,999,400 on March 13, 2024. The transaction will include participation from new investor Human Wellness for 16,666,666 shares. The transaction has been approved by the shareholders of the company and is expected to close on March 18, 2024. The securities are restricted to a hold period of 1 year.
分析記事 • Mar 06Some Confidence Is Lacking In Flask Co., Ltd.'s (KOSDAQ:041590) P/SWhen close to half the companies in the Semiconductor industry in Korea have price-to-sales ratios (or "P/S") below...
New Risk • Nov 14New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩130.4b (US$98.7m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Share price has been volatile over the past 3 months (12% average weekly change). Shareholders have been diluted in the past year (5.4% increase in shares outstanding). Market cap is less than US$100m (₩130.4b market cap, or US$98.7m).
New Risk • Oct 23New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of South Korean stocks, typically moving 11% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Shareholders have been diluted in the past year (8.6% increase in shares outstanding).
New Risk • Oct 10New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₩128.9b (US$95.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-₩20b free cash flow). Minor Risks Shareholders have been diluted in the past year (8.6% increase in shares outstanding). Market cap is less than US$100m (₩128.9b market cap, or US$95.8m).
Reported Earnings • Mar 26Full year 2022 earnings released: ₩188 loss per share (vs ₩237 loss in FY 2021)Full year 2022 results: ₩188 loss per share. Revenue: ₩39.7b (up 65% from FY 2021). Net loss: ₩22.6b (loss widened 15% from FY 2021).
Valuation Update With 7 Day Price Move • Feb 28Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to ₩2,120, the stock trades at a trailing P/E ratio of 29.9x. Average trailing P/E is 17x in the Semiconductor industry in South Korea. Total returns to shareholders of 3.9% over the past three years.
Valuation Update With 7 Day Price Move • Feb 09Investor sentiment improved over the past weekAfter last week's 22% share price gain to ₩2,680, the stock trades at a trailing P/E ratio of 28.9x. Average trailing P/E is 17x in the Semiconductor industry in South Korea. Total returns to shareholders of 26% over the past three years.
Valuation Update With 7 Day Price Move • Dec 01Investor sentiment improved over the past weekAfter last week's 28% share price gain to ₩1,310, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 16x in the Semiconductor industry in South Korea. Total loss to shareholders of 47% over the past three years.
お知らせ • Aug 20GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) acquired additional 12.99% stake in Gemvaxzio Co., Ltd. (KOSDAQ:A041590) for KRW 18.02 billion.GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) acquired additional 12.99% stake in Gemvaxzio Co., Ltd. (KOSDAQ:A041590) for KRW 18.02 billion on August 19, 2021. GemVax&KAEL acquired 10.8 million shares through its own funds and now holds 23.64% stake after completion of the transaction. GemVax&KAEL Co.,Ltd (KOSDAQ:A082270) completed the acquisition of additional 12.99% stake in Gemvaxzio Co., Ltd. (KOSDAQ:A041590) on August 19, 2021.
分析記事 • Apr 10Investors Will Want Gemvaxzio's (KOSDAQ:041590) Growth In ROCE To PersistIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
分析記事 • Mar 06What Type Of Returns Would Gemvaxzio's(KOSDAQ:041590) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?Long term investing is the way to go, but that doesn't mean you should hold every stock forever. It hits us in the gut...
分析記事 • Jan 12Gemvaxzio (KOSDAQ:041590) Is Carrying A Fair Bit Of DebtLegendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Is New 90 Day High Low • Jan 05New 90-day high: ₩847The company is up 14% from its price of ₩744 on 07 October 2020. The South Korean market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 38% over the same period.
Reported Earnings • Nov 19Third quarter 2020 earnings released: ₩34.00 loss per shareThe company reported a solid third quarter result with reduced losses and improved revenues and control over expenses. Third quarter 2020 results: Revenue: ₩10.0b (up 36% from 3Q 2019). Net loss: ₩2.63b (loss narrowed 65% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 49% per year whereas the company’s share price has fallen by 47% per year.
お知らせ • Jul 30Enerzent Co., Ltd. (KOSDAQ:A041590) cancelled the acquisition of an unknown stake in Zio International Inc.Enerzent Co., Ltd. (KOSDAQ:A041590) agreed to acquire an unknown stake in Zio International Inc. for KRW 14.9 billion on June 3, 2019. Under the terms of the transaction, Enerzent will issue 2.8 million new shares for the consideration. Enerzent Co., Ltd. (KOSDAQ:A041590) cancelled the acquisition of an unknown stake in Zio International Inc. on June 3, 2020.
お知らせ • Jul 01+ 1 more updateGemvaxzio Co., Ltd. announced that it has received KRW 12.8 billion in fundingOn June 29, 2020, Gemvaxzio Co., Ltd. (KOSDAQ:A041590) closed the transaction.
お知らせ • Jun 20Gemvaxzio Co., Ltd. announced that it has received KRW 3.49999944 billion in funding from GemVax&KAEL Co.,LtdOn June 18, 2020, Gemvaxzio Co., Ltd. (KOSDAQ:A041590) closed the transaction.